CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...

Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it ...

PLC ("TC BioPharm" or the "Company") (OTC: TCBPY) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

European Patent Office received nearly 200 000 patent applications last year, with Japanese companies and inventors filing 10.6% of the total Electrical machinery/energy, transport and computers ...

Computer technology, which includes areas of AI such as machine learning and pattern recognition, led for the first time, with 16,815 patent applications in 2024. Electrical machinery ...

The European Patent Office’s (EPO) Patent Index 2024, published this week, reveals that nearly 200,000 patent applications were filed last year, proving that Europe’s inventors are pushing ...

European Patent Office (EPO) received nearly 200,000 patent applications last year, with 6.6% coming from the Republic of KoreaStrongest growth globally came from electrical machinery, apparatus ...

According to the latest Patent Index 2024, published today by the European Patent Office (EPO), Japan ranked third worldwide, following the United States and Germany. MUNICH and TOKYO, March 31, 2025 ...

In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...